Hypertension (high blood pressure) Board decisions

The appeal of the claim for service connection for monoclonal gammopathy of unknown significance (MGUS) is dismissed as it has been granted in full.

The Board granted service connection for hypertension under the PACT Act, effective August 10, 2022. The claim based on a different filing date was remanded.

The Board denied earlier effective dates for service connection and ratings, but granted a 10 percent rating for hypertension from May 25, 2021.

The Board granted service connection for a heart condition manifest by cardiac arrhythmia, diabetes mellitus, type II, prostate cancer, hypertension, and eczema based on presumptive exposure to herbicide agents during active service.

The appeal concerning the issues of entitlement to service connection for hypertension and coronary artery disease is dismissed due to the Veteran's death.

The Board granted service connection for hypertension, as secondary to the Veteran's service-connected hypothyroidism with obesity as an intermediate step.

The Board denied an earlier effective date for the 100 percent disability rating for PTSD prior to February 1, 2023, and remanded several service connection claims.

The Board remands the claims for service connection for hypertension, erectile dysfunction, and tinnitus due to a need for additional development of evidence.

The Board granted service connection for hypertension, finding that the evidence was at least evenly balanced as to whether it had onset during active military service.

The Board granted an earlier effective date of February 5, 2021, for the award of service connection for hypertension based on direct service connection and the Veteran's intent to file claim.

The Board denied service connection for diabetes mellitus, type II, hypertension, heart disease (congestive heart failure with arteriosclerotic heart disease, valvular heart disease, cardiomegaly and aortic aneurysm), and hyperlipidemia as the evidence did not support that these conditions were incurred in or aggravated by service.

The Board granted service connection for hypertension, multiple myeloma, prostate cancer, hypothyroidism, and a heart condition as secondary to service-connected hypertension due to herbicide exposure.

The Board granted service connection for hypertension under the Presumption of Service Connection due to herbicide exposure, as provided by the PACT Act. The heart condition claim was remanded for further development.

The Board denied service connection for a right eye disorder, a traumatic brain injury (TBI), and a compensable initial rating for hypertension.

The Board is remanding the issue of entitlement to an initial compensable rating for hypertension due to a pre-decisional duty to assist error in not obtaining all relevant treatment records from Aurora Medical Center.

The Board remands the claim for further development related to the Veteran's exposure to Agent Orange during service.

The Board denied earlier effective dates for service connection and denied increased ratings, except for a 70% rating for major depressive disorder (MDD) from November 21, 2012, and a total disability rating based on individual unemployability due to MDD from the same date. The Board also granted special monthly compensation at the housebound rate from June 10, 2014.

The Board denied an initial compensable rating for hypertension as the Veteran's blood pressure readings did not meet the criteria for a compensable rating.

The Board denied the veteran's claims for increased ratings, earlier effective dates, and service connection for various conditions, as well as nonservice-connected VA death pension benefits.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, atrial fibrillation, sleep apnea syndrome, and mycosis fungoides (also claimed as skin cancer) to ensure the VA has met a duty to assist the Veteran.